MRA/MRV for diagnosing PE

By  |  April 5, 2010 | 

In this multi-center trial of 371 patients with suspected PE, all had MRA/MRV, and the results were compared with the reference standard for diagnosing PE, including clinical assessment, Ddimer, VQ scanning, venous USG, and CTA/CTV. They found that technically adequate scans had good testing characteristics (sensitivity and specificity of 78% and 99% for MRA, and 92% and 96% for MRA/MRV) but inadequate scanning rates ranged from 11% to 52% at different centers. MRA/MRV has excellent testing characteristics, but only at centers where technically adequate scans can be routinely performed (abstract)

Leave A Comment

About the Author:

Danielle Scheurer
Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.


Related Posts

By  | July 2, 2015 |  0
I am coming up on my two year anniversary. Not my wedding anniversary (soon to be 15 years – thanks Maia!), but two years since I joined the ranks of the patients. It was two years ago this week that my day was interrupted by a page from my internist saying, “I don’t know how […]
By  | September 8, 2014 |  3
  As you can see, no glamour shots for this month’s post. I knew it would come at some point, and my first hospitalization related to my CLL came in a big way in mid-July. Given my interest in global health, it was only fitting that I managed to get sick while out of the […]
By  | July 6, 2013 |  0
This large multicenter trial randomized patients with acute VTE to apixaban (10mg BID for 1 week, followed by 5mg BID for 6 months) versus conventional therapy (lovenox-warfarin). The primary outcome was similar between groups (symptomatic VTE or death related to VTE), but major and minor bleeding occurred significantly less often with apixaban. Apixaban is a […]